25 years of Miltenyi Biotec

For a quarter century, Miltenyi Biotec has helped brilliant minds advance scientific discovery and cellular therapies. On our 25th anniversary, we look back at the milestones that got us where we are today, and the breakthroughs that inspire us for tomorrow.
Happy anniversary, Miltenyi Biotec!

Happy anniversary, Miltenyi Biotec!

Here you’ll find a special edition of our Listen to the Experts series that you might already know from Miltenyi TV. Just click on the video message below.

 
 
 
 
Miltenyi Biotec is founded

Miltenyi Biotec is founded

The magnetic cell separation technology developed by Stefan Miltenyi provides the firm basis for Miltenyi Biotec and would become the industry standard.

MACS® Technology

MACS® Technology
The magnetic cell separation technology developed by Stefan Miltenyi provides the firm basis for Miltenyi Biotec and would become the industry standard.

 
Expansion to the U.S.

Expansion to the U.S.

Miltenyi Biotec expands to North America with its U.S. headquarters in Northern California,
and would later go on to open offices in other biotechnology hubs, Boston and San Diego.

 
Dies ist die Testheadline
Dies ist die Testheadline
 
CliniMACS® System

CliniMACS® System

A joint venture with Amgen is formed to develop the technology that would become the basis for the industry-changing CliniMACS System.

 
Expansion to the UK

Expansion to the UK

Miltenyi Biotec opens the UK subsidiary in Bisley, Surrey, just outside of London.

 
CE marking in Europe

CE marking in Europe

The CliniMACS System receives its CE marking as an approved medical device in Europe.
 

 
Expansion to Southern Europe

Expansion to Southern Europe

New subsidiaries in France, Italy, and Spain enlarge the Miltenyi Biotec family.

 
autoMACS® Separator

autoMACS® Separator

Miltenyi Biotec launches the autoMACS Separator – at that time the only automated magnetic
cell separator.

 
Expansion to Asia-Pacific

Expansion to Asia-Pacific

Miltenyi Biotec opens its first Asia subsidiary in China, and would later go on to open subsidaries in Japan, Singapore, Australia, and South Korea.
 

 
GMP facility opens

GMP facility opens

Miltenyi Biotec aquires PlasmaSelect and purchases a state-of-the-art manufacturing facility in Germany for the production of GMP-compliant devices, consumables, and reagents.

 
Expansion to Benelux

Expansion to Benelux

Miltenyi Biotec making moves to Belgium, Netherlands, and Luxembourg to foster future  growth especially in the field of cellular therapy.


 
autoMACS® Pro Separator

autoMACS® Pro Separator

Launch of the autoMACS Pro Separator, the most advanced automated cell separation instrument on the market.

 
MACSQuant® Flow Cytometers
MACSQuant® Flow Cytometers

Miltenyi Biotec introduces a new design approach to flow cytometers with easy-to-use  instruments for researchers at all levels.
 
gentleMACS™ Dissociator

gentleMACS™ Dissociator

The acquisition of the Swiss company Medic Tools leads to the development of the successful gentleMACS™ Dissociator instruments.

 
Expansion to Northern Europe

Expansion to Northern Europe

The Nordic subsidiary is opened in Sweden, covering Scandinavia, the Baltic countries, and Iceland.

 
CliniMACS Prodigy®
CliniMACS Prodigy®

This GMP-compliant instrument offers advanced solutions for automating cell-processing workflows.
 
MACSQuant® Tyto

MACSQuant® Tyto

Miltenyi Biotec acquires Owl biomedical and develops the revolutionary microchip-based flow sorting instrument, MACSQuant Tyto.
 
FDA approval

FDA approval

Miltenyi Biotec receives its first FDA approval, for the CliniMACS CD34 Reagent System.

 
Lentigen Technology

Lentigen Technology

Miltenyi Biotec acquires Lentigen Technology Inc., a global leader in lentiviral technology for cell and gene therapy applications.
 

Contact

Miltenyi Biotec K.K.
TEL +81 3 5646 8910
FAX+81 3 5646 8911
macs@miltenyibiotec.jp
お問い合わせ

Product finder

Antibody panel builder

Toolbox

Loading...

Change country

Please select your country to continue